Blood Pressure · 2005 · 32 citations · 39 references
Life SciencesBiochemistryPharmacologyBiochemical PharmacologyNeuropharmacologyRedox BiochemistryCerebrovascular DiseaseCerebrovascular PhysiologyEndothelial DysfunctionLipid PeroxidationNeuroprotectionStrokeCommon Carotid ArteryControl Group DesignEndothelial Function ModulationGlutathione Peroxidase ActivityMatched Control GroupNitric OxideOxidative Stress In Cardiovascular DiseaseVascular Endothelial Dysfunction
BACKGROUND: To investigate whether extrinsic antioxidant seleno-glutathione peroxidase mimic ebselen (PZ51) can protect endothelium and vascular structure of stroke-prone spontaneously hypertensive rats (SHRsp) during the chronic process of hypertension. METHODS: Twenty-two 8-week-old SHRsp were randomized into a PZ51 group and a control group, and administered by gavage for 6 weeks. We examined the level of nitric oxide (NO) and malonaldehyde (MDA) in plasma. The intima-media thickness (IMT) of the common carotid artery (CCA) was measured by an image-analysis system. The endothelium of the CCA was observed by scanning electron microscopy. The eNOS protein of the major artery was assayed by immunohistochemistry and western blotting. RESULTS: Compared with the control group, PZ51 decreased plasma MDA (7.88+/-1.06 vs 10.88+/-1.73 nmol/l, p<0.001) and increased plasma NO (40.02+/-9.74 vs 22.22+/-10.05 micromol/l, p<0.001), increased eNOS protein expression (8.25+/-2.36 vs 4.46+/-3.14, p=0.026), decreased IMT (69.85+/-5.47 vs 76.60+/-6.53 microm, p<0.05) significantly and alleviated the damage to the endothelium of the CCA. CONCLUSION: Administration of PZ51 for 6 weeks can protect the endothelium and inhibit vascular remodeling, maybe due to its suppression of lipid peroxide formation and increase in eNOS protein expression.
39
Common Carotid Intima-Media Thickness and Risk of Stroke and Myocardial Infarction
Michiel L. Bots, Arno W. Hoes, Peter J. Koudstaal et al. · Circulation · 1997 · 2.3K citations